Skip to main content

Table 4 Thromboembolic events within 14 days of 4F-PCC administration

From: Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors

Thromboembolic event

n (%)

Total

1 (2.3)

Deep vein thrombosis

1 (2.3)

Pulmonary embolism

0

Myocardial infarction

0

Cerebral vascular accident

0

Arterial thrombosis of limb

0

Arterial thrombosis of mesenteries

0